Sidney Schnoll, M.D., Ph.D.

Vice President, Pharmaceutical Risk Management


Sidney (Sid) H. Schnoll is an internationally recognized expert in addiction and pain management who applies his experience of over 30 years in academic medicine to the issues of pharmaceutical risk management. In his strategic leadership role, Sid counsels clients and provides strategic input on:

  • Regulatory and scientific strategy
  • Development, implementation, and assessment of risk management activities, including engagement with the FDA
  • Risk assessment during early product development, and development of Risk Evaluation and Mitigation Strategies (REMS)
  • Postmarketing surveillance reports for submission to FDA


Sid has served on numerous committees and boards including the FDA’s Drug Abuse Advisory Committee (DAAC), National Institutes of Health (NIH) study sections, National Board of Medical Examiners test development committees, and the board of the College on Problems of Drug Dependence (CPDD).

Sid was a member of the team that developed the Tramadol Independent Steering Committee (ISC), which resulted in Ultram being launched as an unscheduled analgesic and monitored for abuse and diversion. As part of the ISC, he was the principal investigator on the health care professional surveillance project. In 2001, Sid joined Purdue Pharma L.P. where he developed the RADARS® System to study the abuse and diversion of prescription opioids. He is currently a member of the RADARS® System Scientific Advisory Board and Industry Advisory Board.

Sid has held several academic positions. He was the Career Teacher in Addictions at the University of Pennsylvania, after which he was Medical Director at the Eagleville Hospital and Rehabilitation Center, which is noted for many innovations in the treatment of addictive diseases. In 1980, he became Associate Professor of Psychiatry and Pharmacology and Director of Chemical Dependence programs at Northwestern University Medical School. In 1986, he became Professor of Internal Medicine and Psychiatry at the Medical College of Virginia, Virginia Commonwealth University and Chairman of the Division of Substance Abuse Medicine. He also held faculty positions in the departments of Pharmacology and Toxicology and Psychology at Virginia Commonwealth University. Additionally, he held a position as a Voluntary Professor of Behavioral Science at the University of Kentucky.

Sid has received numerous awards including listings in The Best Doctors in America and is a Fellow of the College on Problems of Drug Dependence and the American Society of Addiction Medicine. He has published over 150 research papers, book chapters and educational materials.


  • Completed his internship, residency in neurology and doctorate in pharmacology at Jefferson Medical College (now the Sidney Kimmel Medical College)
  • Earned his medical degree at the New Jersey College of Medicine and Dentistry
  • Graduated from Union College